Abstract:Insufficient vascularization is a major challenge in the repair of critical-sized bone defects. Deferoxamine (DFO) has been reported to play a potential role in promoting the formation of H-type blood vessels, a specialized vascular subtype with coupled angiogenesis and osteogenesis. However, whether DFO promotes the expression of H-type vessels in critical femoral defects with complete periosteal damage remains unknown. Moreover, stable drug loading systems need to be designed owing to the short half-life and high-dose toxic effects of DFO. In this study, we developed an injectable DFO-gelatin microspheres (GMs) hydrogel complex as a stable drug loading system for the treatment of critical femoral defects in rats. Our results showed that sustained release of DFO in critical femoral defects stimulated the generation of functional H-type vessels. The DFO-GMs hydrogel complex effectively promoted proliferation, formation, and migration of human umbilical vein endothelial cells in vitro. In vivo , the application of the DFO-GMs hydrogel complex expanded the distribution range and prolonged the expression time of H-type vessels in the defect area and was positively correlated with the number of osterix+ cells and new bone tissue. Topical application of the HIF-1α inhibitor PX-478 partially blocked the stimulation of H-type vessels by DFO, whereas the osteogenic potential of the latter was also weakened. Our results extended the local application of DFO and provided a theoretical basis for targeting H-type vessels to treat large femoral defects. Statement of Significance Abundant functional blood vessels are essential for bone repair. The H-type blood vessel is a functional subtype with angiogenesis and osteogenesis coupling potential. A drug loading system with long-term controlled release was first used to investigate the formation of H-type blood vessels in critical femoral defects and promotion of bone repair. Our results showed that the application of DFO-GMs hydrogel complex expanded the distribution range and expression time of H-type vessels, and was positively correlated with the number of osteoblasts and volume of new bone tissue. These results expanded the local application approach of DFO and provide a theoretical basis for targeting H-type vessels to treat large femoral defects.

Deferoxamine Released from Poly(lactic-Co-glycolic Acid) Promotes Healing of Osteoporotic Bone Defect Via Enhanced Angiogenesis and Osteogenesis.

Angiogenic And Osteogenic Coupling Effects Of Deferoxamine-Loaded Poly(Lactide-Co-Glycolide)-Poly(Ethylene Glycol)-Poly(Lactide-Co-Glycolide) Nanoparticles

Hierarchical Composite Scaffold with Deferoxamine Delivery System to Promote Bone Regeneration via Optimizing Angiogenesis

Drug-Delivery Nanoplatform with Synergistic Regulation of Angiogenesis-Osteogenesis Coupling for Promoting Vascularized Bone Regeneration

Injectable temperature-sensitive hydrogel system incorporating deferoxamine-loaded microspheres promotes H-type blood vessel-related bone repair of a critical size femoral defect

Activating Angiogenesis and Immunoregulation to Propel Bone Regeneration via Deferoxamine-Laden Mg-Mediated Tantalum Oxide Nanoplatform

Deferoxamine/magnesium modified β-tricalcium phosphate promotes the bone regeneration in osteoporotic rats

The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads

Advances in Hypoxia-Inducible Factor-1α Stabilizer Deferoxamine in Tissue Engineering.

Electrospun Artificial Periosteum Loaded With Dfo Contributes To Osteogenesis Via The Tgf-Beta 1/Smad2 Pathway

Deferoxamine enhances bone regeneration in mandibular distraction osteogenesis

SF-deferoxamine, a Bone-Seeking Angiogenic Drug, Prevents Bone Loss in Estrogen-Deficient Mice

Effects of Deferoxamine on the Osteogenic Differentiation of Human Periodontal Ligament Cells.

Deferoxamine Immobilized Poly(d,l-Lactide) Membrane Via Polydopamine Adhesive Coating: the Influence on Mouse Embryo Osteoblast Precursor Cells and Human Umbilical Vein Endothelial Cells.

3D-printed dimethyloxallyl glycine delivery scaffolds to improve angiogenesis and osteogenesis

Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice.

Deferoxamine-Loaded Chitosan-Based Hydrogel on Bone Implants Showing Enhanced Bond Strength and Pro-Angiogenic Effects

Desferoxamine protects against glucocorticoid‐induced osteonecrosis of the femoral head via activating HIF‐1α expression

An Injectable Thermosensitive Hydrogel Containing Resveratrol and Dexamethasone‐Loaded Carbonated Hydroxyapatite Microspheres for the Regeneration of Osteoporotic Bone Defects

Deferoxamine Accelerates Mandibular Condylar Neck Fracture Early Bone Healing by Promoting Type H Vessel Proliferation

Injectable, oxygen-releasing, thermosensitive hydrogel promotes vascularized bone formation with prolonged oxygen delivery and improved osteoinductivity